Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19 - Takeaways - MDSpire

Engagement of chymase-positive mast cells in myocardial damage associated with COVID-19

  • By

  • Andrey V. Budnevsky

  • Sergey N. Avdeev

  • Ekaterina D. Arkhipova

  • Djuro Kosanovic

  • Viktoria V. Shishkina

  • Tatiana A. Chernik

  • Evgeniy S. Ovsyannikov

  • Inna M. Perveeva

  • Andrey A. Filin

  • Roman E. Tokmachev

  • Alexander V. Pertsev

  • Elena E. Ivanova

  • Tatiana V. Samoylenko

  • Lyubov N. Antakova

  • May 7, 2026

  • 0 min

Share

  • 1

    Chymase-positive mast cells (MCs) are implicated in myocardial injury among patients who died from severe COVID-19.

  • 2

    A low density of cardiac MCs was observed, with a significant presence of degranulated chymase-positive cells.

  • 3

    Chymase-positive MCs correlated with severe COVID-19 indicators, including elevated troponin I levels and inflammatory markers.

  • 4

    Increased MC presence was associated with extensive interstitial and perivascular fibrosis, primarily type III collagen.

  • 5

    The study suggests targeting chymase-positive MCs may help mitigate cardiac complications in future coronavirus-related diseases.

Original Source(s)

Related Content